YKL-40 interacts with a variety of extracellular matrix components and with invasive and metastatic processes of tumor cells in lung cancer, cholangiocarcinoma, endometrial cancer, and other malignancies [56–58]. This evidence concerns the gene CHI3L1 and lung carcinoma.